株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中国のエソメプラゾール市場の分析

Investigation Report on China Esomeprazole Market, 2010-2019

発行 China Research and Intelligence 商品コード 297281
出版日 ページ情報 英文 30 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
中国のエソメプラゾール市場の分析 Investigation Report on China Esomeprazole Market, 2010-2019
出版日: 2015年05月28日 ページ情報: 英文 30 Pages
概要

中国では現在、1億2000万人もの人々が胃腸系の疾患に罹患しており、そのうちの10%が消化性潰瘍、30%が慢性胃炎の患者と見られています。エソメプラゾール(商品名「Nexium」)はAstra Zenecaによって開発された抗潰瘍薬で、中国でも2004年に上市され、2005〜2014年に年平均(CAGR)48%もの速度で市場を拡大してきました。ただし、その高収益に着目した他企業の参入が近年相次いでいることから、今後は市場シェアが低下するものと思われます。

当レポートでは、中国におけるエソメプラゾールの市場について分析し、中国国内での生産高および病院向け売上高・価格の動向(過去5年間分)、企業別・投薬形態別の市場シェア、将来的な市場動向の見通し(今後5年間分)などを調査して、その結果をお届けします。

第1章 エソメプラゾールの関連概念

  • 開発プロセスと症状
  • 世界市場での販売状況

第2章 中国のエソメプラゾール市場の概要

  • 主要メーカー
  • 特許の現状
  • 市場規模

第3章 エソメプラゾールの売上高の分析

  • 総売上高
  • 地域別の売上高

第4章 主要メーカーの市場シェアの分析

  • 市場シェア(金額ベース)
  • 市場シェア(数量ベース)

第5章 剤形別の市場規模の分析

  • 剤形別の市場シェア(金額ベース)
  • 剤形別の市場シェア(数量ベース)

第6章 エソメプラゾールの病院向け基準価格(企業別)

  • AstraZeneca(Wuxi)
  • AstraZeneca(Sweden)
  • Chongqing LUMMY Pharmaceutical Co., Ltd.

第7章 主要メーカーの分析

  • AstraZeneca(Wuxi)
  • AstraZeneca(Sweden)
  • Chongqing LUMMY Pharmaceutical Co., Ltd.

第8章 中国のエソメプラゾール市場の将来展望

  • 中国での消化器疾患の発症傾向
  • ジェネリック医薬品の現状
  • 市場規模の予測
  • 競争パターンの予測

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 1505180

Digestive system disease is one of frequently-occurring diseases. According to statistics of WHO, there are at least 250 million digestive tract patients, mainly suffering from canker.

Inhibition of gastric acid secretion is the key treatment method for peptic ulcer, duodenal ulcer and gastroesophageal reflux disease. The H+ / K+ ATP enzyme in gastric parietal cells can reduce gastric acid secretion. By inhibiting the functioning of this transporter, the drug prevents formation of gastric acid. Proton pump inhibitor, namely H+/K+-ATP enzyme, inhibits the avidity of H+/K+-ATP enzyme to block gastric acid secretion caused by any stimulation

Esomeprazole is a proton pump inhibitor that appeared on the market in 2000. It becomes popular in the market because of high bioavailability, effective and lasting inhibition of gastric acid and low toxic and side effect. Total sales revenue of Nexium (trade name of esomeprazole produced by Astra Zeneca) since it was launched is over tens of billions dollars, making it one of the most important products from Astra Zeneca. Patent No. 94190335. 4 is the most crucial patent for Nexium which expires in May 2014. To avoid time-consuming and costly patent infringement lawsuits, Astra Zeneca announced in October 2011 that generic drug manufacturers with cooperation intention needed to pay royalty before producing esomeprazole generic drugs. Though generic drugs take part of Nexium's market, Astra Zeneca can recoup the loss by charging patent royalty.

Statistics shows that there are over 120 million people suffering from enterogastric diseases in China, which is the most in the world. Incidence of peptic ulcer is 10% while that of chronic gastritis is 30%.

Nexium produced by Astra Zeneca entered China in 2004. According to CRI's investigation in China market, the CAGR of sales revenue of esomeprazole outstepped 48% from 2005 to 2014. In 2014, the sales value in sample hospital exceeded CNY 80 million, which was spectacularly successful. By the end of 2014, Chinese market was absolutely dominated by products from Astra Zeneca.

Chongqing LUMMY Pharmaceutical Co., Ltd. applied for 4 new drug registrations with esomeprazole in 2010, which was approved in August 2013. It is estimated that market pattern of esomeprazole in China will change in 2015. In the short term Nexium produced by Astra Zeneca will still have an absolute advantage in the market, but its market share will decline in the long run.

Through this report, the readers can acquire the following information:

  • Sales Price of Esomeprazole (Nexium) in China Hospital Market
  • Major Esomeprazole Manufacturers in China

Patent Status of Esomeprazole in China

  • Share of Esomeprazole in Different Dosage Forms in China Hospital Market
  • Prospect of China Esomeprazole Market

The Following Enterprises and People Are Recommended to Purchase This Report:

  • Manufacturers of Digestive System Diseases Medication
  • Investors on China Digestive System Diseases Drug Market

Table of Contents

1. Relevant Concepts of Esomeprazole

  • 1.1. Development Process and Indication
  • 1.2. Sales Status on the Global Market

2. Market Overview of Esomeprazole in China, 2010-2014

  • 2.1. Major Manufacturers
  • 2.2. Patent Status
  • 2.3. Market Size

3. Investigation on Sales Value of Esomeprazole in China, 2010-2014

  • 3.1. Total Sales Value
  • 3.2. Sales Value by Region

4. Investigation on Market Share of Major Esomeprazole Manufacturers in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Investigation on Market Size of Esomeprazole by Dosage Form in China, 2010-2014

  • 5.1. Market Share by Sales Value and Dosage Form
  • 5.2. Market Share by Sales Volume and Dosage Form

6. Reference Price of Esomeprazole Produced by Different Enterprises in China Hospital Market

  • 6.1. AstraZeneca(Wuxi)
  • 6.2. AstraZeneca(Sweden)
  • 6.3. Chongqing LUMMY Pharmaceutical Co., Ltd.

7. Major Manufacturers in China Esomeprazole Market, 2011-2014

  • 7.1. AstraZeneca(Wuxi)
  • 7.2. AstraZeneca(Sweden)
  • 7.3. Chongqing LUMMY Pharmaceutical Co., Ltd.

8. Market Prospect of Esomeprazole in China, 2014- 2018

  • 8.1. Digestive System Disease Incidence in China
  • 8.2. Status of Generic Drugs
  • 8.3. Forecast on Market Size
  • 8.4. Forecast on Competition Pattern

Selected Charts

  • Chart Esomeprazole Products Approved to Market in China by 2015
  • Chart Sales Value of Esomeprazole in Global Market, 2010-2014
  • Chart Esomeprazole Products Sold in China Market
  • Chart Patent Status of Esomeprazole in China
  • Chart Sales Value of Esomeprazole in Hospital Market in China, 2010-2014
  • Chart Sales Value of Esomeprazole by Region in China, 2010-2014
  • Chart Market Share of Esomeprazole Enterprises by Sales Value in China, 2010-2014
  • Chart Price of Esomeprazole Produced by AstraZeneca ( Wuxi) in China Hospital Market, 2014
  • Chart Forecast on Market Size of Hospital-use Esomeprazole in China, 2014-2018
Back to Top